New insights into atherosclerotic plaque rupture.
作者信息
Braganza D M, Bennett M R
机构信息
Box 110, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.
出版信息
Postgrad Med J. 2001 Feb;77(904):94-8. doi: 10.1136/pmj.77.904.94.
Abstract
摘要
相似文献
1
New insights into atherosclerotic plaque rupture.
Postgrad Med J. 2001 Feb;77(904):94-8. doi: 10.1136/pmj.77.904.94.
2
3
Elucidation of the role of plaque instability and rupture in acute coronary events.
Am J Cardiol. 1995 Sep 28;76(9):24C-33C. doi: 10.1016/s0002-9149(99)80467-6.
4
New morphological insights on coronary plaque rupture: bridging the gap from anatomy to clinical presentation?
JACC Cardiovasc Interv. 2011 Jan;4(1):83-6. doi: 10.1016/j.jcin.2010.11.005.
5
Finally: the proof of concept--from animal studies, imaging and the clinical evidence of plaque rupture.
Atherosclerosis. 2010 Dec;213(2):367-8. doi: 10.1016/j.atherosclerosis.2010.09.001. Epub 2010 Oct 20.
6
Very late bare metal stent thrombosis due to neoatherosclerotic plaque rupture: an optical coherence tomography finding.
Heart. 2012 Oct;98(19):1470. doi: 10.1136/heartjnl-2012-302019. Epub 2012 May 30.
7
CT for prediction of plaque erosion resulting in myocardial infarction with non-obstructive coronary arteries.
J Cardiovasc Comput Tomogr. 2017 May-Jun;11(3):237-239. doi: 10.1016/j.jcct.2017.02.009. Epub 2017 Feb 22.
8
Factors determining and prevention of atherosclerotic plaque rupture.
Postgrad Med J. 1994;70 Suppl 1:S43-5.
9
The severity of coronary atherosclerosis at sites of plaque rupture with occlusive thrombosis.
J Am Coll Cardiol. 1991 Apr;17(5):1138-42. doi: 10.1016/0735-1097(91)90844-y.
10
Pathophysiology and clinical significance of atherosclerotic plaque rupture.
Cardiovasc Res. 1999 Feb;41(2):323-33. doi: 10.1016/s0008-6363(98)00322-8.
引用本文的文献
1
Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors.
Front Cardiovasc Med. 2023 Jun 2;10:1186679. doi: 10.3389/fcvm.2023.1186679. eCollection 2023.
2
The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.
Front Pharmacol. 2022 May 20;13:867500. doi: 10.3389/fphar.2022.867500. eCollection 2022.
3
Carotid Intima-Media Thickness, Genetic Risk, and Ischemic Stroke: A Family-Based Study in Rural China.
Int J Environ Res Public Health. 2020 Dec 26;18(1):119. doi: 10.3390/ijerph18010119.
4
A Control-Theoretic Model of Atherosclerosis.
Int J Mol Sci. 2019 Feb 12;20(3):785. doi: 10.3390/ijms20030785.
5
Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress.
Sci Rep. 2017 Apr 4;8:45917. doi: 10.1038/srep45917.
6
Clinical significance of macrophage phenotypes in cardiovascular disease.
Clin Transl Med. 2014 Nov 21;3(1):63. doi: 10.1186/s40169-014-0042-1. eCollection 2014 Dec.
7
Plaque regression and plaque stabilisation in cardiovascular diseases.
Indian J Endocrinol Metab. 2013 Nov;17(6):983-9. doi: 10.4103/2230-8210.122604.
8
Statins as first-line therapy for acute coronary syndrome?
Exp Clin Cardiol. 2012 Winter;17(4):227-36.
9
Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.
Indian J Clin Biochem. 2010 Apr;25(2):133-40. doi: 10.1007/s12291-010-0025-y. Epub 2010 May 27.
10
Atheromas feel the pressure: biomechanical stress and atherosclerosis.
Am J Pathol. 2010 Jul;177(1):4-9. doi: 10.2353/ajpath.2010.090615. Epub 2010 Jun 17.
本文引用的文献
1
Inhibition of proinflammatory cytokine production by pravastatin.
Lancet. 1999 Mar 20;353(9157):983-4. doi: 10.1016/S0140-6736(98)05917-0.
2
Mechanisms of progression in native coronary artery disease: role of healed plaque disruption.
Heart. 1999 Sep;82(3):265-8. doi: 10.1136/hrt.82.3.265.
3
Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells.
Kidney Int Suppl. 1999 Jul;71:S198-201. doi: 10.1046/j.1523-1755.1999.07151.x.
4
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.
Circulation. 1999 Jul 20;100(3):230-5. doi: 10.1161/01.cir.100.3.230.
5
Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability.
Cardiovasc Res. 1999 Feb;41(2):480-8. doi: 10.1016/s0008-6363(98)00318-6.
6
Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques.
Cardiovasc Res. 1999 Feb;41(2):473-9. doi: 10.1016/s0008-6363(98)00311-3.
7
Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation.
Cardiovasc Res. 1999 Feb;41(2):345-60.
8
Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity.
Circulation. 1999 Jan 26;99(3):348-53. doi: 10.1161/01.cir.99.3.348.
9
Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma.
Circ Res. 1998 Nov 16;83(10):1015-26. doi: 10.1161/01.res.83.10.1015.
10
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages.
Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1671-8. doi: 10.1161/01.atv.18.11.1671.
Zotero 插件